Wellington Management Group’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.9M Sell
341,005
-43,745
-11% -$3.99M ﹤0.01% 969
2025
Q4
$50M Sell
384,750
-10,981
-3% -$1.51M 0.01% 736
2025
Q3
$42.6M Sell
395,731
-10,842
-3% -$1.18M 0.01% 785
2025
Q2
$37.5M Sell
406,573
-19,074
-4% -$1.5M 0.01% 764
2025
Q1
$37.7M Buy
425,647
+284,855
+202% +$24.7M 0.01% 775
2024
Q4
$10.8M Buy
+140,792
New +$9.83M ﹤0.01% 1174
2022
Q2
Sell
-5,231
Closed -$530K 2209
2022
Q1
$530K Sell
5,231
-1,913
-27% -$213K ﹤0.01% 1901
2021
Q4
$1.05M Buy
7,144
+2,367
+50% +$529K ﹤0.01% 1791
2021
Q3
$1.2M Hold
4,777
﹤0.01% 1769
2021
Q2
$2.21M Buy
4,777
+1,059
+28% +$455K ﹤0.01% 1658
2021
Q1
$1.83M Buy
+3,718
New +$1.93M ﹤0.01% 1643

Other funds holding WGS

Wellington Management Group's WGS Position: Q1 2026 in Review

Wellington Management Group reduced its GeneDx Holdings (WGS) stake by 11% in Q1 2026, selling an estimated $3.99M and leaving 341,005 shares worth $21.9M. The position accounts for ﹤0.01% of the portfolio, ranked #969.

Wellington Management Group first reported a position in WGS in Q1 2021 and has held it in 11 quarters since. The position peaked at $50M in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Wellington Management Group held 341,005 shares of GeneDx Holdings worth $21.9M as of Q1 2026.
  • Wellington Management Group sold 43,745 GeneDx Holdings shares in Q1 2026, an estimated $3.99M.
  • GeneDx Holdings made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #969 holding.
  • Wellington Management Group first reported a position in GeneDx Holdings in Q1 2021 and has held it in 11 quarters since.
  • Wellington Management Group's GeneDx Holdings position peaked at $50M in Q4 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.